Historically redlined neighborhoods reveal a disturbing link to higher rates of heart failure among Black residents, underscoring the long-lasting health impact of this discriminatory practice.
Read More
The ISCHEMIA trial explores how age affects health status and clinical outcomes in older adults with chronic coronary disease. Invasive management’s impact on angina-related health and overall outcomes reveals important considerations for treatment decisions.
Read More
The FDA cautions health providers to stop using the Quidel Triage Cardiac Panel due to potential inaccuracies in troponin levels. Alternatives are recommended to ensure accurate diagnoses for myocardial infarction.
Read More
Medtronic has issued a Class I recall for certain implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators. The recall affects hundreds of thousands of devices with potential energy output issues during high voltage therapy.
Read More
Ground-breaking research points to a low-dose regimen of the drug carvedilol as a potential game-changer in the fight against heart failure among childhood cancer survivors. This study paves the way for a more proactive approach towards protecting the heart health of this high-risk group, highlighting a potential paradigm shift in their long-term care.
Read More